Cloning and site-directed mutagenesis. pET22b(+) was used as a cloning and expression vector for all enzymes described in this study. Site-directed mutagenesis was performed using a modified QuikChange TM mutagenesis protocol. The PCR products were gel purified, digested with DpnI, repaired using Gibson Mix TM , and used to directly transform E. coli strain
BL21(DE3).
Determination of P411 concentration. The concentration of P411 enzymes in whole cell experiments was determined from ferrous carbon monoxide binding difference spectra using the previously reported extinction coefficient for serine-ligated enzymes (ε = 103,000 M -1 cm -1 ). 1 The concentration of purified P411 enzymes was determined by quantifying the amount of free hemin present using the pyridine/hemochrome assay.
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Expression and amination bioconversions using whole cells. E. coli BL21(DE3) cells transformed with plasmid encoding P411 variants were grown overnight in 5 mL Luria-Bertani medium with 0.1 mg/mL ampicillin (LB amp , 37 ºC, 250 rpm). The preculture was used to inoculate 45 mL of Hyperbroth medium (prepared from AthenaES© powder, 0.1 mg/mL ampicillin) in a 125 mL Erlenmeyer flask; this culture was incubated at 37 ºC, 230 rpm for 2 h.
Cultures were then cooled on ice (20 min) and induced with 0.5 mM IPTG and 0.5 mM 5-aminolevulinic acid (final concentrations). Expression was conducted at room temperature, 130 rpm, for 16 h. Cultures were then centrifuged (2,600 x g, 10 min, 4 ºC) and the pellets resuspended to OD 600 = 30 in M9-N. Aliquots of the cell suspension (4 mL) were used to determine the P411 expression level after lysis by sonication.
For amination bioconversions, the cells at OD 600 = 30 in M9-N were degassed by sparging with argon in sealed 6 mL crimp vials for at least 40 minutes. Separately, glucose (250 mM in M9-N) was degassed by sparging with argon for at least five minutes. To 2 mL crimp vials were added an oxygen depletion system (20 µL of a stock solution containing 14,000 U/mL catalase and 1,000 U/mL glucose oxidase in 0.1 M KPi, pH 8.0). All solutions were uncapped and transferred into an anaerobic chamber. Resuspended cells (320 µL) were added to the vials, Reaction screening in 96-well plate format. Site-saturation libraries were generated employing the "22c-trick" method. 3 E. coli libraries were cultured in LB amp (300 µL/well) at 37 ºC, 220 rpm.
Hyperbroth medium (1000 µL/well, 0.1 mg/mL ampicillin) was inoculated with the preculture (50 µL/well) and incubated at 37 ºC, 220 rpm, 80% humidity for 3 h. The plates were cooled on ice for 30 minutes and then induced with 0.5 mM IPTG and 1 mM 5-aminolevulinic acid (final 4 concentrations). Expression was conducted at 20 ºC, 120 rpm for 24 h. The cells were pelleted (3,000 x g, 5 min, 4 ºC) and resuspended in the oxygen depletion system (20 µL/well). The 96-well plate was then transferred to an anaerobic chamber. In the anaerobic chamber, argonsparged reaction buffer (50 mM glucose in M9-N, 300 µL/well) was added, followed by sulfide (10 µL/well, 200 mM in DMSO) and tosyl azide (10 µL/well, 200 mM in DMSO). The plate was sealed with an aluminum foil, removed from the anaerobic chamber, and shaken at 40 rpm. After 16 hours, the seal was removed and acetonitrile (400 µL/well) and internal standard (10 µL/well of a DMSO stock) were added. The wells were mixed, the plate was centrifuged (5,000 x g, 10 min), and the supernatant was filtered through an AcroPrep 96-well filter plate (0.2 µm) into a shallow-well plate for HPLC analysis.
For the screening of site-saturation libraries for activity on sulfide 1, we used batches of sulfide 1 favoring the E-alkene (3:1 or 4.5:1 E:Z) for the first three libraries (at residues A268, L437, and S438), while for the next set of libraries (at residues A78, A82, T260, and P329) we performing screening using Z-1 (>15:1 Z:E). Myoglobin (equine heart) and cytochrome c (bovine heart) were purchased from Sigma-Aldrich.
Synthesis of substrates.
Thioanisole and ethyl phenyl sulfide were purchased from Sigma-Aldrich and used without further purification. Other sulfides were synthesized according to known procedures, and their spectral data are in agreement with reported values. 4 Tosyl azide was prepared according to de Nanteuil and Waser. 5 (Z)-But-2-en-1-yl(phenyl)sulfide (Z-1) was prepared in two steps via Lindlar hydrogenation of 2-butyn-1-ol according to Balduzzi et al. 6 followed by mesylation and displacement with thiophenolate according to Hiroi and Makino. 7 The sulfide was obtained in 26% yield from (Z)- 
Characterization of reaction products.
Authentic standards corresponding to enzymatic reaction products were prepared by tosylation of the corresponding allylic amine or by nitrene transfer to the corresponding sulfide according to the method of Okamura and Bolm. 8 Phenylthiosulfonamides were cleaved to the corresponding sulfonamides by treatment with 0.5 M potassium hydroxide in methanol, according to Murakami Table S1 . Mutations present in P450 BM3 variants used in this work.
N-(2-Methylbut-3-en-2-yl)-4-methylbenzenesulfonamide

S-(n-Propyl)-S-phenyl-N-(4-methylbenzenesulfonyl)sulfimide
S-(n-Butyl)-S-phenyl-N-(4-methylbenzenesulfonyl)sulfimide
Variant Mutations relative to wild-type P450 BM3
P411 BM3 -CIS T438S (P)   V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, T268A,   A290V, L353V, I366V, C400S, T438S, E442K   P-I263F  V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, I263F, T268A, A290V, L353V, I366V, C400S, T438S, E442K P-I263F A328V V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, I263F, T268A, A290V, A328V, L353V, I366V, C400S, T438S, E442K P-I263F V87A V78A, F87A, P142S, T175I, A184V, S226R, H236Q, E252G, I263F, T268A, A290V, L353V, I366V, C400S, T438S, E442K P-I263F V87A   A328V   V78A, F87A, P142S, T175I, A184V, S226R, H236Q, E252G, I263F,   T268A, A290V, A328V, L353V, I366V, C400S, T438S, E442K   P-I263F V87A   A328V A268G   V78A, F87A, P142S, T175I, A184V, S226R, H236Q, E252G, I263F,   T268G, A290V, A328V, L353V, I366V, C400S, T438S, E442K   P-I263F V87A   A328V A268G A82L   V78A, A82L, F87A, P142S, T175I, A184V, S226R, H236Q, E252G,   I263F, T268G, A290V, A328V, L353V, I366V, C400S, T438S, E442K   P-I263F V87A   A328V A268G A82I   V78A, A82I, F87A, P142S, T175I, A184V, S226R, H236Q, E252G,   I263F, T268G, A290V, A328V, L353V, I366V , C400S, T438S, E442K Table S4 . Reactions performed with purified proteins (and hemin). In addition, Boc-L-alanine methyl ester was derivatized according to the procedures of Moriwake et al. 13 and Velmourougane et al., 14 providing 10 as the (S) enantiomer. The enantiopurity of the material was eroded to 68% ee during the reaction sequence, but the major peak matched that observed in the P411-catalyzed reactions, confirming assignment of the enzymatic product as the (S) enantiomer.
S-Ethyl-S-phenyl-N-(4-methylbenzenesulfonyl)
sulfimide (12) was prepared racemically and separated by chiral HPLC to >99% ee using a Chiralcel OJ-H column. The enantiomer formed preferentially by variant P-5, which elutes first on the Chiralcel OJ-H column (using 12% 
S-(n-Propyl)-S-phenyl-N-(4-methylbenzenesulfonyl)sulfimide (18)
was prepared by a semipreparative enzymatic reaction. Two whole cell bioconversions were performed using 12.8 mL cells overexpressing variant P-5, resuspended to OD 600 = 10 in M9-N. To the degassed cells in an anaerobic chamber were added the oxygen depletion system (800 µL), glucose (1.6 mL, 250 mM in M9-N), phenyl n-propyl sulfide (400 µL, 300 mM in DMSO), and tosyl azide (400 µL, 300 mM in DMSO). After 18 h, the reactions were diluted with 16 mL acetonitrile and centrifuged 
